Ivermectin the Promising Drug to Stave off the COVID-19 Crisis: A Review

Authors

  • Zakia Jahan MPH from the George Washington University, USA. Director of Center for Human Development
  • Masudul Hassan MD in Cardiologist, Professor, & Director, Metropolitan Learning Institute, New York, USA

DOI:

https://doi.org/10.3329/bjid.v7i2.51520

Keywords:

Covid-19; pandemic; Ivermectin.

Abstract

The Coronavirus disease 2019 (COVID-19) outbreak, forcing us to face unprecedented moments in the world. The huge devastating impact of the world due to the covid-19 attack causes the brink of no return. However, there is no proven and specific treatment for Covid -19. Very few medications have received Emergency Use of Authorization. A recent in vitro study was the first time to find out and to assess the antiviral effect of Ivermectin on COVID-19. The study showed that Ivermectin was active against COVID- 19-infected cells, was able to kill effectively almost all viral particles within 48 h. In these moments of crisis, FDA-approved ivermectin is a ray of hope.

Bangladesh Journal of Infectious Diseases 2020;7(2):95-98

Downloads

Download data is not yet available.
Abstract
875
PDF
646

Downloads

Published

2021-01-20

How to Cite

Jahan, Z., & Hassan, M. (2021). Ivermectin the Promising Drug to Stave off the COVID-19 Crisis: A Review. Bangladesh Journal of Infectious Diseases, 7(2), 95–98. https://doi.org/10.3329/bjid.v7i2.51520

Issue

Section

Review Articles